Windtree Therapeutics - Warrants (25/03/2026) (WINT+) Q3 2018 Earnings

14NovExpected
Q4 2017
Q1 2018
Q2 2018
Q3 2018
-3.12
-1.81
-0.5
0.81

Details

Expected EPS
N/A
Actual EPS
-3.12
Surprise EPS
-3.12
Surprise Percent
+∞%

Description

Windtree Therapeutics - Warrants (25/03/2026) (WINT+) has reported earnings of -3.12 per share for Q3 2018.

0 Comments

Share your thoughts